| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 03/20/2023 | VYNE Therapeutics Inc. | MNLO | Purchase | Common Stock | 20k | $2.48 | $49.7k | | 03/20/2023 |
| 08/10/2022 | VYNE Therapeutics Inc. | MNLO | Grant | Stock Options | 20.5k | $0.31 | $6.4k | | 08/10/2022 |
| 05/16/2022 | LANNETT CO INC | LCI | Purchase | Common Stock | 50k | $0.54 | $27k | | 05/16/2022 |
| 02/08/2022 | LANNETT CO INC | LCI | Purchase | Common Stock | 50k | $0.88 | $44k | | 02/08/2022 |
| 11/30/2021 | VYNE Therapeutics Inc. | MNLO | Purchase | Common Stock | 12.5k | $1.02 | $12.7k | | 11/30/2021 |
| 11/29/2021 | LANNETT CO INC | LCI | Purchase | Common Stock | 50k | $1.71 | $85.5k | | 11/29/2021 |
| 09/08/2021 | LANNETT CO INC | LCI | Purchase | Common Stock | 20k | $3.31 | $66.2k | | 09/08/2021 |
| 08/31/2021 | LANNETT CO INC | LCI | Grant | Common Stock | 56.8k | $0.00 | $0 | | 08/31/2021 |
| 08/25/2021 | VYNE Therapeutics Inc. | MNLO | Purchase | Common Stock | 12.5k | $1.60 | $20k | | 08/25/2021 |
| 07/19/2021 | VYNE Therapeutics Inc. | MNLO | Grant | Stock Options | 20.5k | $2.75 | $56.4k | | 07/19/2021 |
| 05/26/2021 | VYNE Therapeutics Inc. | MNLO | Purchase | Common Stock | 12.5k | $3.60 | $45k | | 05/26/2021 |
| 03/15/2021 | VYNE Therapeutics Inc. | MNLO | Purchase | Common Stock | 12.5k | $7.41 | $92.6k | | 03/15/2021 |
| 12/03/2020 | VYNE Therapeutics Inc. | MNLO | Purchase | Common Stock | 50k | $1.71 | $85.4k | | 12/03/2020 |
| 11/02/2020 | Matinas BioPharma Holdings, Inc. | MTNB | Grant | Stock option (right to buy) | 122.6k | $0.82 | $100.5k | | 11/02/2020 |
| 09/10/2020 | VYNE Therapeutics Inc. | MNLO | Grant | Stock Options | 45k | $1.46 | $65.7k | | 09/10/2020 |
| 09/01/2020 | LANNETT CO INC | LCI | Grant | Common Stock | 39k | $0.00 | $0 | | 09/01/2020 |
| 05/14/2020 | Matinas BioPharma Holdings, Inc. | MTNB | Purchase | Common Stock, par value $0.0001 per share | 100k | $0.73 | $73k | | 05/14/2020 |
| 11/15/2019 | Matinas BioPharma Holdings, Inc. | MTNB | Purchase | Common Stock, par value $0.0001 per share | 100k | $1.06 | $105.5k | | 11/15/2019 |
| 11/01/2019 | Matinas BioPharma Holdings, Inc. | MTNB | Grant | Stock option (right to buy) | 107.4k | $0.91 | $98k | | 11/01/2019 |
| 09/03/2019 | LANNETT CO INC | LCI | Purchase | Common Stock | 25k | $9.82 | $245.5k | | 09/03/2019 |
| 08/16/2019 | Matinas BioPharma Holdings, Inc. | MTNB | Purchase | Common Stock, par value $0.0001 per share | 100k | $0.72 | $71.8k | | 08/16/2019 |
| 07/19/2019 | LANNETT CO INC | LCI | Grant | Common Stock | 33.4k | $0.00 | $0 | | 07/19/2019 |
| 05/16/2019 | Matinas BioPharma Holdings, Inc. | MTNB | Purchase | Common Stock, par value $0.0001 per share | 100k | $0.95 | $95.2k | | 05/16/2019 |
| 05/08/2019 | LANNETT CO INC | LCI | Purchase | Common Stock | 25k | $7.32 | $183k | | 05/08/2019 |
| 02/12/2019 | LANNETT CO INC | LCI | Purchase | Common Stock | 25k | $8.93 | $223.2k | | 02/12/2019 |
| 12/13/2018 | LANNETT CO INC | LCI | Purchase | Common Stock | 25k | $5.10 | $127.5k | | 12/13/2018 |
| 11/01/2018 | Matinas BioPharma Holdings, Inc. | MTNB | Grant | Stock option (right to buy) | 128.3k | $0.74 | $94.9k | | 11/01/2018 |
| 09/05/2018 | Matinas BioPharma Holdings, Inc. | MTNB | Grant | Option (right to buy) | 150k | $0.44 | $66k | | 09/05/2018 |
| 08/31/2018 | LANNETT CO INC | LCI | Purchase | Common Stock | 25k | $5.34 | $133.5k | | 08/31/2018 |
| 07/20/2018 | LANNETT CO INC | LCI | Grant | Common Stock | 16.2k | $0.00 | $0 | | 07/20/2018 |
| 05/11/2018 | LANNETT CO INC | LCI | Purchase | Common Stock | 25k | $15.13 | $378.2k | | 05/11/2018 |
| 12/07/2017 | PharMerica CORP | PMC | Disposition | Common Stock, $0.01 par value | 29.6k | $29.25 | $864.9k | | 12/07/2017 |
| 06/14/2017 | PharMerica CORP | PMC | Grant | Common Stock, $0.01 par value | 4.8k | $0.00 | $0 | | 06/14/2017 |
| 06/19/2015 | PharMerica CORP | PMC | Grant | Common Stock, $0.01 par value | 3.7k | $0.00 | $0 | | 06/19/2015 |
| 06/17/2014 | PharMerica CORP | PMC | Grant | Common Stock, $0.01 par value | 4.3k | $0.00 | $0 | | 06/17/2014 |
|